Lotus Leaf (<i>Nelumbo nucifera</i>) and its Active Constituents Prevent Inflammatory Responses in Macrophages via JNK/NF-κB Signaling Pathway

American Journal of Chinese Medicine - Tập 42 Số 04 - Trang 869-889 - 2014
Shing‐Hwa Liu1, Tien-Hui Lu2,3, Chin‐Chuan Su4,3, Ing‐Shiow Lay5,6, Hui‐Yi Lin7, Kai‐Min Fang8,3, Tsung-Jung Ho9, Kuo‐Liang Chen10, Yi‐Chang Su9, Wenchang Chiang11, Ya‐Wen Chen2,3
1Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan
2Department of Physiology, China Medical University, Taichung, Taiwan
3Graduate Institute of Basic Medical Science, College of Medicine, China Medical University, Taichung, Taiwan
4Department of Otorhinolaryngology, Head and Neck Surgery, Changhua Christian Hospital, Changhua, Taiwan
5School of Post-Baccalaureate Chinese Medicine, China Medical University, Taichung, Taiwan
6The Division of Chinese Medicine, China Medical University Beigang Hospital, Taiwan
7School of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan
8Department of Otolaryngology, Far Eastern Memorial Hospital, Taipei, Taiwan
9School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan
10Department of Urology, China Medical University Hospital, Taichung, Taiwan
11Graduate Institute of Food Science and Technology, National Taiwan University, Taipei, Taiwan

Tóm tắt

Inflammation is a serious health issue worldwide that induces many diseases, such as inflammatory bowel disease (IBD), sepsis, acute pancreatitis and lung injury. Thus, there is a great deal of interest in new methods of limiting inflammation. In this study, we investigated the leaves of Nelumbo nucifera Gaertn, an aquatic perennial plant cultivated in eastern Asia and India, in anti-inflammatory pharmacological effects in the murine macrophage cell line RAW264.7. Results showed that lipopolysaccharide (LPS) increased the protein expression of inducible nitric oxide synthase (iNOS) and COX-2, as well as the mRNA expression and level of IL-6 and TNF-α, while NNE significantly reduced these effects of LPS. LPS also induced phospho-JNK protein expression. The JNK-specific inhibitor SP600125 decreased the proteins expression of phospho-JNK, iNOS, COX-2, and the mRNAs expression and levels of IL-6 and TNF-α. Further, NNE reduced the protein expression of phospho-JNK. LPS was also found to promote the translocation of NF-κB from the cytosol to the nucleus and to decrease the expression of cytosolic IκB. NNE and SP600125 treatment recovered the LPS-induced expression of NF-κB and IκB. While phospho-ERK and phospho-p38 induced by LPS, could not be reversed by NNE. To further investigate the major components of NNE in anti-inflammatory effects, we determined the quercetin and catechin in inflammatory signals. Results showed that quercetin and catechin significantly decreased the proteins expression of iNOS, COX-2 and phospho-JNK. Besides, the mRNAs and levels of IL-6 and TNF-α also decreased by quercetin and catechin treatment in LPS-induced RAW264.7 cells. These results showed that NNE and its major components quercetin and catechin exhibit anti-inflammatory activities by inhibiting the JNK- and NF-κB-regulated pathways and could therefore be an useful anti-inflammatory agent.

Từ khóa


Tài liệu tham khảo

10.1093/carcin/bgi114

10.1016/j.lfs.2003.10.042

10.1042/0264-6021:3570593

10.1136/thorax.57.5.452

10.1002/eji.200324569

10.1016/0753-3322(94)90005-1

10.1016/S0006-2952(00)00255-0

10.1016/j.toxlet.2010.09.016

10.1016/j.intimp.2010.12.008

10.1189/jlb.0308178

10.1097/00006454-200102000-00018

10.1111/j.1745-7254.2007.00579.x

Feuerstein G. Z., 1994, Cerebrovasc. Brain Metab. Rev., 6, 341

10.1038/nri2423

Gilchrist M., 2002, J. Leukoc. Biol., 71, 618, 10.1189/jlb.71.4.618

10.1007/s11010-011-0785-6

10.1073/pnas.97.26.14022

10.1007/s10753-011-9385-6

10.1007/s00066-003-1044-x

10.1016/j.bcp.2012.11.002

10.1016/S0898-6568(01)00182-6

10.1021/jf103382h

10.1016/j.intimp.2013.01.008

10.1016/j.bbamcr.2006.12.009

10.1038/aps.2012.52

10.1155/2012/153568

10.1186/1742-2094-10-1

10.1016/j.febslet.2006.08.025

10.1007/s00011-012-0545-4

10.1021/jf900950z

10.1016/j.lfs.2004.01.019

10.1007/s10753-012-9484-z

10.1016/j.toxlet.2010.11.019

10.1016/j.toxlet.2013.10.013

10.1016/S0968-0004(97)01147-X

Mercer B. A., 2006, Int. J. Chron. Obstruct. Pulmon. Dis., 1, 137

10.1152/ajpgi.00133.2012

10.1093/jnen/63.9.901

Moncada S., 1991, Pharmacol. Rev., 43, 109

10.1074/jbc.M302942200

10.1155/2008/186584

Park H. Y., 2012, Int. J. Mol. Med., 29, 1146

10.1186/1476-511X-11-76

10.4049/jimmunol.1003551

Ristimaki A., 1994, J. Biol. Chem., 269, 11769, 10.1016/S0021-9258(17)32638-8

10.3748/wjg.14.200

10.1056/NEJMoa050333

10.1007/s00441-010-1092-3

10.1142/S0192415X10008408

Xie Q. W., 1994, J. Biol. Chem., 269, 4705, 10.1016/S0021-9258(17)37600-7

Zamora R., 2000, Mol. Med., 6, 347, 10.1007/BF03401781